相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
Marc Brisson et al.
LANCET (2020)
Efficacy of HPV Vaccination in Women Receiving LEEP for Cervical Dysplasia: A Single Institution's Experience
Marco Petrillo et al.
VACCINES (2020)
Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study
Giorgio Bogani et al.
GYNECOLOGIC ONCOLOGY (2020)
Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016
Xavier Martinez-Gomez et al.
EUROSURVEILLANCE (2019)
Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia
Louiza S. Velentzis et al.
GYNECOLOGIC ONCOLOGY (2019)
Oral and anal high-risk human papilloma virus infection in HIV-positive men who have sex with men over a 24-month longitudinal study: complexity and vaccine implications
Saverio Giuseppe Parisi et al.
BMC PUBLIC HEALTH (2019)
Oral and systemic HPV antibody kinetics post-vaccination among HIV-positive and HIV-negative men
Ligia A. Pinto et al.
VACCINE (2019)
Cervical intraepithelial neoplasia in women who had vaccination against HPV
Giorgio Bogani et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2019)
Safety and efficacy of human papillomavirus vaccination for people living with HIV: A systematic review and meta-analysis
Yongle Zhan et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2019)
Nomogram-based prediction of cervical dysplasia persistence/recurrence
Giorgio Bogani et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2019)
The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment
Giorgio Bogani et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia
Karen Canfell et al.
BMJ OPEN (2018)
SPERANZA project: HPV vaccination after treatment for CIN2+
Alessandro Ghelardi et al.
GYNECOLOGIC ONCOLOGY (2018)
Screening for Cervical Cancer US Preventive Services Task Force Recommendation Statement
Susan J. Curry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Investigational drugs for the treatment of cervical cancer
Fabio Barra et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment
Allan Hildesheim et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
Cosette M. Wheeler et al.
LANCET INFECTIOUS DISEASES (2016)
High Rates of Incident and Prevalent Anal Human Papillomavirus Infection Among Young Men Who Have Sex With Men
Sara Nelson Glick et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Immunogenicity of Quadrivalent Human Papillomavirus Vaccine in Organ Transplant Recipients
D. Kumar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)?
Woo Dae Kang et al.
GYNECOLOGIC ONCOLOGY (2013)
Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study
Mark E. Scott et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
Matti Lehtinen et al.
LANCET ONCOLOGY (2012)
Anogenital Malignancies in Women After Renal Transplantation Over 40 Years in a Single Center
Kim A. P. Meeuwis et al.
TRANSPLANTATION (2012)
High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patients
M. Reuschenbach et al.
BRITISH JOURNAL OF CANCER (2011)
End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age
X. Castellsague et al.
BRITISH JOURNAL OF CANCER (2011)
Human papillomavirus infection and anal dysplasia in renal transplant recipients
H. S. Patel et al.
BRITISH JOURNAL OF SURGERY (2010)
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial
Nubia Munoz et al.
LANCET (2009)
Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years
Anne Andermann et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2008)
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
Andrew E. Grulich et al.
LANCET (2007)
Human papillomavirus in the oral cavity of patients with and without renal transplantation
Barbara Rose et al.
TRANSPLANTATION (2006)
Prophylactic human papillomavirus vaccines
DR Lowy et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
分享论文
